Corient Private Wealth’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
Other funds holding ACAD
BBA
Corient Private Wealth's ACAD Position: Q3 2026 in Review
Corient Private Wealth opened a new position in Acadia Pharmaceuticals (ACAD) in Q3 2026: 54,612 shares worth $1.1M. The stake represents ﹤0.01% of the portfolio and ranks #1974 among its holdings.
351 funds tracked by Wall St. Rank hold ACAD as of Q3 2026.
- Corient Private Wealth held 54,612 shares of Acadia Pharmaceuticals worth $1.1M as of Q3 2026.
- Acadia Pharmaceuticals was a new Corient Private Wealth position in Q3 2026.
- Acadia Pharmaceuticals made up ﹤0.01% of Corient Private Wealth's portfolio in Q3 2026, its #1974 holding.
- 351 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2026.
Based on Corient Private Wealth's 13F filing for Q3 2026, filed 16 Nov 2026.